Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits.

In addition to longstanding evidence from observational studies, evidence from randomised trials of the effectiveness of aspirin for chemoprevention of colorectal cancer has increased substantially in recent years. Trials have shown that daily aspirin reduces the risk of any recurrent colorectal ade...